Cancer

Use of Prostate Health Index test reduces unnecessary biopsies

The Prostate Health Index (phi) is a cost-effective tool used by urologists to detect prostate cancer. It reduces the risk of over diagnosis, and cuts down on the need to send men for unnecessary and often uncomfortable biopsies. ...

Cancer

Prostate cancer—what you need to know

In 2016, more than 180,890 men will be diagnosed with prostate cancer, the second leading cause of cancer death in men. Next to skin cancers, prostate cancer is the most common cancer diagnosed in American men.

Cancer

Urine test improves prediction of high-grade prostate cancer

An experimental urine test that detects genetic changes associated with prostate cancer identified 92 percent of men with elevated PSA (prostate-specific antigen) levels who had high-grade cancers, according to a study published ...

Cancer

The dilemma of screening for prostate cancer

Primary care providers are put in a difficult position when screening their male patients for prostate cancer—some guidelines suggest that testing the general population lacks evidence whereas others state that it is appropriate ...

Cancer

New approach to prostate cancer screening needed, expert says

(Medical Xpress)—The UK needs to invest in testing for those men most at risk of prostate cancer rather than follow a cast-the-net-wide approach targeting the whole population, a leading scientist from The University of ...

Health

AAFP adds five more 'Choosing Wsely' recommendations

(HealthDay)—Five additional recommendations have been made as part of the Choosing Wisely campaign, according to a report published by the American Academy of Family Physicians (AAFP).

page 1 from 2